Dietary folate and vitamin B6 are not associated with p53 mutations in esophageal adenocarcinoma

Molecular Carcinogenesis

Volumn 49, Issue 3, 2010, Pages 211-214

  Balbuena, Lloyd ^a   Casson, Alan G ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adenocarcinoma; Esophagus; Folate; p53; Vitamin b6

Indexed keywords

FOLIC ACID; PROTEIN P53; PYRIDOXINE; TP53 PROTEIN, HUMAN;

ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DIET; ESOPHAGEAL ADENOCARCINOMA; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SMOKING HABIT; TOBACCO; VITAMIN INTAKE; ADENOCARCINOMA; BARRETT ESOPHAGUS; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; ESOPHAGUS TUMOR; GASTROESOPHAGEAL REFLUX; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PROMOTER REGION; QUESTIONNAIRE;

NICOTIANA TABACUM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; CPG ISLANDS; DIET; ESOPHAGEAL NEOPLASMS; FOLIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOENZYME TECHNIQUES; MUTATION; PROMOTER REGIONS, GENETIC; QUESTIONNAIRES; TUMOR SUPPRESSOR PROTEIN P53; VITAMIN B 6;

EID: 77949903311     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20602     Document Type: Article

References (23)

1. Kim YI. Folic acid supplementation and cancer risk: Point. Cancer Epidemiol Biomark Prev 2008;17:2220-2225.
2. Ulrich CM. Folate and cancer prevention - Where to next? Cancer Epidemiol Biomark Prev 2008;17:2226-2230.
3. Sauer J, Mason JB, Choi SW. Too much folate: A risk for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009;12:30-36.
4. Yang Q, Bostick RM, Friedman JM, Flanders WD. Serum folate and cancer mortality among US adults: Findings from the third national health and nutritional examination survey linked mortality file. Cancer Epidemiol Biomark Prev 2009; 18:1439-1447.
5. Sohn KJ, Stempak JM, Reid S, Shirwadkar S, Mason JB, Kim YI. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 2003;24:81-90. (Pubitemid 36193198)
6. Crott JW, Liu Z, Choi SW, Mason JB. Folate depletion in human lymphocytes up-regulates p53 expression despite marked induction of strand breaks in exons 5-8 of the gene. Mut Res 2007;626:171-179. (Pubitemid 44881413)
7. Schernhamer ES, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology 2008;135:770-780.
8. Liu Z, Choi SW, Crott JW, Smith DE, Mason JB. Multiple B-vitamin inadequacy amplifies alterations induced by folate depletion in p53 expression and its downstream effector MDM2. Int J Cancer 2008;123:519-525. (Pubitemid 351898408)
9. Zhang ZF, Kurtz RC, Yu GP, et al. Adenocarcinoma of the esophagus and gastric cardia: The role of diet. Int J Cancer 1997;27:289-309.
10. Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomark Prev 2001;10:1055-1062. (Pubitemid 32959152)
11. Chen H, Tucker KL, Graubard BI, et al. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 2002;42:33-40. (Pubitemid 35007004)
12. Bollschweiler E, Wolfgarten E, Nowroth T, Rosendahl U, Monig SP, Holscher AH. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol 2002;128:575-580. (Pubitemid 35244934)
13. Casson AG, Zheng Z, Evans SC, et al. Cyclin D1 polymorphism G870A and risk for esophageal adenocarcinoma. Cancer 2005;104:730-739. (Pubitemid 41113671)
14. Casson AG, Zheng Z, Evans SC, Veuglers PJ, Porter GA, Guernsey DL. Polymorphisms of DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 2005;26:1536-1541. (Pubitemid 41236046)
15. Veuglers PJ, Porter GA, Guernsey DL, Casson AG. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006;19:321-328.
16. Casson AG, Zheng Z, Porter GA, Guernsey DL. Polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect Prev 2006;30:423-431.
17. Macdonald K, Porter GA, Guernsey DL, Zhao R, Casson AG. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma. Cancer Epidemiol 2009;33:37-40.
18. Vaninetti N, Williams L, Geldenhuys L, Porter GA, Guernsey DL, Casson AG. Regulation of CDX2 expression in esophageal adenocarcinoma. Mol Carcinog 2009. 48:965-974.
19. Vaninetti NM, Geldenhuys L, Porter GA, et al. Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Mol Carcinog 2008;47:275-285. (Pubitemid 351500153)
20. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 2008;100:1184-1187.
21. Vollset SE, Igland J, Jenab M, et al. The association of gastric cancer risk with plasma folate, cobalamin, and methylene-tetrahydrofolate reductase polymorphisms in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomark Prev 2007;16:2416-2424. (Pubitemid 351196375)
22. Skinner HG, Michaud DS, Giovannucci EL, et al. A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol 2004;160:248-258. (Pubitemid 39006781)
23. Ulrich CM, Neuhouser M, Liu AY, et al. Mathematical modeling of folate metabolism: Predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomark Prev 2008;17: 1822-1831.